regeneron glp-1 gip treatment muscle loss side effects GRK-biased adrenergic agonists for the of type 2 diabetes and obesity The new drug, which is taken in tablet form, has a completely different mechanism of action than the well-known GLP-1-based The GLP-1 race may have

Choose a consistent day and time for weekly injectionsideally the same day each week to build habit

& Hung, K

GLP-1 medications may carry risks including thyroid C-cell tumors (including thyroid cancer) and medullary thyroid carcinoma (MTC)

Options at that point may include switching medications, adding adjunctive therapy, investigating underlying conditions like hypothyroidism or PCOS, or reassessing whether this medication class is right for you

European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP), 20 (3), 225-239

None of these drugs work as well as semaglutide or tirzepatide, experts say, but they may help with weight loss maintenance